Kala Pharmaceuticals, Inc. (KALA) NASDAQ

9.66

+0.355(+3.82%)

Updated at February 05 02:00PM

Currency In USD

Valuation

Market Cap17.02M
Enterprise Value2.45M
P/E Ratio-1.11
PEG Ratio-0.1
Price/Sales Ratio812.3
Price/Book Ratio6.3
Enterprise/Revenue638.55
Enterprise/EBITDA-1.36

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-556.61
Operating Margin-581.53

Management Effectiveness

Return On Assets-0.72
Return On Equity-4.49

Income Statement

Revenue0
Revenue/Share0.02
Gross Profit-303,000
EBITDA-36.08M
Net Income-42.2M
Diluted EPS-17.35

Balance Sheet

Total Cash49.2M
Total Cash/Share10.63
Total Debt37.04M
Total Debt/Equity5.4
Current Ratio2.15
Book Value Per Share1.48

Price History

52-Week Change33.93
52-Week High9.74
52-Week Low4.21
Moving Average 50 Days7.04
Moving Average 200 Days6.49

Statistics

Average Volume46,177
Shares Outstanding6.09M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateOctober 21, 2022